Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Inventiva S.A. (IVA)

5.175   0.305 (6.26%) 08-19 01:46
Open: 5.175 Pre. Close: 4.87
High: 5.175 Low: 4.88
Volume: 230 Market Cap: 215(M)
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.04 - 5.06 5.06 - 5.09
Low: 4.8 - 4.84 4.84 - 4.87
Close: 4.96 - 5.01 5.01 - 5.05

Technical analysis

as of: 2022-08-18 3:53:48 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 6.52     One year: 7.62
Support: Support1: 4.78    Support2: 4.28
Resistance: Resistance1: 5.59    Resistance2: 6.52
Pivot: 4.84
Moving Average: MA(5): 5.18     MA(20): 4.89
MA(100): 7.74     MA(250): 10.99
MACD: MACD(12,26): -0.2     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 62.2     %D(3): 67.9
RSI: RSI(14): 49.4
52-week: High: 15.77  Low: 4.28
Average Vol(K): 3-Month: 29 (K)  10-Days: 2 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ IVA ] has closed below upper band by 22.7%. Bollinger Bands are 31.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 18 Aug 2022
Weddle, Iva Leo - NRVN News

Thu, 18 Aug 2022
The Global Intelligent Virtual Assistant (IVA) Based Banking Market size is expected to reach $5.1 billion by 2028, rising at a market growth of 24.3% CAGR during the forecast period - GlobeNewswire

Thu, 18 Aug 2022
Iva L. Seefeldt | News, Sports, Jobs - Fairmont Sentinel

Wed, 17 Aug 2022
What Kind Of Investors Own Most Of Inventiva S.A. (EPA:IVA)? - Simply Wall St

Sun, 14 Aug 2022
Iva Whitson Obituary (1938 - 2022) - Vinton, VA -

Sat, 13 Aug 2022
Iva Lea Carter | Local | - Rapid City Journal

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 41 (M)
Shares Float 14 (M)
% Held by Insiders 0 (%)
% Held by Institutions 11.9 (%)
Shares Short 136 (K)
Shares Short P.Month 128 (K)

Stock Financials

EPS -1.34
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.17
Profit Margin (%) 0
Operating Margin (%) -613.2
Return on Assets (ttm) -25
Return on Equity (ttm) -49.7
Qtrly Rev. Growth 81.8
Gross Profit (p.s.) 0.18
Sales Per Share 0.2
EBITDA (p.s.) -1.26
Qtrly Earnings Growth 0
Operating Cash Flow -48 (M)
Levered Free Cash Flow -24 (M)

Stock Valuations

PE Ratio -3.89
PEG Ratio 0
Price to Book value 2.38
Price to Sales 24.88
Price to Cash Flow -4.45

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.